Related Experiment Video
Updated: Jun 19, 2026
06:58
Physiology Lab Demonstration: Glomerular Filtration Rate in a Rat
Published on: July 26, 2015
FACTORS WHICH DETERMINE RENAL WEIGHT : XI. RENAL FUNCTION
1Department of Medicine, Stanford University Medical School, San Francisco.
The Journal of Experimental Medicine
|October 30, 2009
Summary
Kidney weight in albino rats directly correlates with renal function. This study establishes a proportional relationship between the amount of functioning renal tissue and kidney function metrics.
Area of Science:
- Nephrology
- Physiology
- Animal Models
Background:
- Renal function assessment is crucial in physiological studies.
- Quantifying functioning renal tissue provides insights into kidney health.
- Albino rats are a common model for studying renal physiology.
Purpose of the Study:
- To investigate the relationship between renal tissue mass and renal function.
- To establish a quantitative correlation between kidney weight and renal function.
- To explore the direct proportionality under specific experimental conditions.
Main Methods:
- Measuring kidney weight in albino rats as a proxy for functioning renal tissue.
- Assessing renal function using specific physiological ratios (detailed in PDF).
- Analyzing the direct proportionality between kidney weight and renal function metrics.
Main Results:
- A direct proportional relationship was observed.
- Kidney weight was found to be a reliable indicator of functioning renal tissue.
- The established ratio demonstrated a clear correlation with renal mass.
Conclusions:
- Kidney weight serves as a valid and direct measure of functioning renal tissue in albino rats.
- Renal function is directly proportional to the amount of functioning renal tissue.
- This finding supports the use of kidney weight as a biomarker in renal studies.
Related Concept Videos
01:17Factors Affecting Renal Clearance: Renal Impairment
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:31Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted less...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted less...
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
01:24Serum Studies: Renal Function Tests
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...